Company Overview
About Cardinal Health
Cardinal Health, Inc. is a Dublin, Ohio-based healthcare distribution and medical products company — publicly traded on the New York Stock Exchange (NYSE: CAH) as an S&P 500 Health Care component — distributing pharmaceutical products to pharmacies, hospitals, and healthcare providers, and manufacturing and distributing medical and surgical supplies through approximately 44,000 employees. In fiscal year 2025 (ending June 2025), Cardinal Health generated revenues exceeding $230 billion in its Pharmaceutical and Specialty Solutions segment — reflecting the company's role as a pass-through distributor of branded and generic pharmaceuticals at near-zero margin on drug cost, where Cardinal Health earns distribution fees and rebate income on enormous volumes. CEO Jason Hollar has executed a two-segment strategy focused on optimizing pharmaceutical distribution (Pharmaceutical and Specialty Solutions — $227B+ revenue at low margin) and growing medical products profitability (Global Medical Products and Distribution — higher-margin branded surgical products, Cardinal Health brand commodities, and at-Home Solutions). The 2024 divestiture of the medical segment's Cardinal Health Brand product line to Medline Industries for $1.1 billion simplified the medical segment focus toward specialty distribution and home healthcare supply. Cardinal Health's specialty pharmaceutical distribution (oncology, rheumatology, rare disease biologics through Cardinal Health Specialty Solutions) is a growing higher-margin subsegment as pharmaceutical manufacturers contract with specialty distributors for controlled dispensing of limited-distribution drugs.
Business Model & Competitive Advantage
Cardinal Health's pharmaceutical distribution model creates structural competitive position through the extraordinary capital efficiency of drug distribution: Cardinal Health acts as the financial intermediary between pharmaceutical manufacturers (Pfizer, Eli Lilly, Novo Nordisk) and pharmacies (CVS, Walgreens, independent pharmacies), purchasing pharmaceutical inventory, warehousing it at Cardinal Health distribution centers, and delivering to tens of thousands of pharmacy locations daily — earning distribution service fees and generic pharmaceutical program rebates while turning inventory 50+ times per year. The specialty pharmaceutical distribution growth (GLP-1 receptor agonists Ozempic and Wegovy distribution through Cardinal Health's Specialty Solutions network) creates disproportionate volume growth as semaglutide prescriptions reached 60+ million in 2024, requiring specialty distribution infrastructure that Cardinal Health provides to physicians, clinics, and specialty pharmacies. Cardinal Health's medical segment at-Home Solutions business — distributing ostomy supplies, wound care products, incontinence products, and enteral nutrition directly to patients' homes — benefits from the shift of post-acute care from hospital settings to home care as payors (Medicare, Medicaid, commercial insurers) increasingly prefer lower-cost home-based care.
Competitive Landscape 2025–2026
In 2025, Cardinal Health competes in pharmaceutical distribution and medical supply against McKesson Corporation (NYSE: MCK, $309B revenue, largest US drug distributor), AmerisourceBergen/Cencora (NYSE: COR, $265B revenue), and Medline Industries (private, medical-surgical distribution) for pharmacy distribution contracts, specialty pharmaceutical distribution agreements, and medical product supply relationships with hospitals and healthcare systems. The GLP-1 drug distribution opportunity — Novo Nordisk and Eli Lilly ramping Ozempic, Wegovy, Mounjaro, and Zepbound supply through 2025-2026 — creates volume tailwind for Cardinal Health's pharmaceutical distribution segment as the single largest new pharmaceutical category in decades flows through the wholesale distribution infrastructure. The 2025 strategy focuses on specialty pharmaceutical distribution growth (oncology, immunology, rare disease), at-Home Solutions patient direct distribution expansion, and medical segment profitability improvement following the Medline divestiture.
The Cardinal Health Story
Founders
Company Timeline
Major milestones in Cardinal Health's journey
Leadership Team
Meet the leaders behind Cardinal Health
Jason Hollar
Jason Hollar became CEO in September 2022 after serving as Chief Financial Officer since May 2020. Under his leadership, Cardinal Health has achieved record financial performance through strategic focus on simplification and prioritization, with Q3 fiscal 2025 operating earnings hitting $807 million. He serves on the boards of Cardinal Health, Red Oak Sourcing, DaVita Kidney Care, and Junior Achievement of Central Ohio.
Aaron Alt
Aaron Alt serves as Chief Financial Officer for Cardinal Health, leading financial activities including strategy, capital deployment, treasury, tax, investor relations, accounting and reporting, as well as corporate development activities across the enterprise. He was appointed CFO in December 2022 and received $6.8 million in compensation in fiscal 2024.
Stephen Mason
Stephen M. Mason leads Cardinal Health's Global Medical Products and Distribution segment, overseeing the manufacturing and distribution of medical, surgical, and laboratory products. He was the company's second-highest paid executive at $7.3 million in fiscal 2024, up 66% from the previous year, reflecting the segment's strong performance.
Deborah Weitzman
Deborah L. Weitzman serves as CEO of the Pharmaceutical and Specialty Solutions segment, leading Cardinal Health's largest business unit that distributes pharmaceuticals to pharmacies, hospitals, and specialty practices nationwide. Her compensation was nearly $5.1 million for fiscal 2024, up 25% from the previous year.
Robert D. Walter
Robert D. Walter founded Cardinal Health in 1971 at age 25 and served as the longest-tenured chairman of a company of Cardinal Health's size. He grew the business from a small food distributor to a diversified healthcare giant before retiring in 2008 after 37 years of visionary leadership.
Open Positions
Reddit Discussions
Key Differentiators
Market Leader
Cardinal Health is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $230000M in revenue, Cardinal Health operates at enterprise scale with proven market validation.
Frequently Asked Questions
Not So Random Others
YouShift
YouShift is a United States-based AI healthcare workforce management platform — building the operating system for healthcare staffing starting with AI-powered scheduling agents that replace the comple
Hermes Robotics
Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Bucket Robotics
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
Dusty Robotics
Dusty Robotics is a Mountain View, California-based construction robotics company — backed with $69.5 million in total funding from Root Ventures, Scale Venture Partners, Canaan Partners, GRIDS Capita
Compare Cardinal Health with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Cardinal Health? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Cardinal Health Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Cardinal Health vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →